All Type of News
The counterattack of BSM aims Samjin, United, JW and IldongKeeping the top position in prescriptions, Baraclude (BMS) has started to counterattack.
According to the industry concerned, Bristol-Myers Squibb Holdings Island owning the pe...
|
The conflict between Hanmi Pharm and the Korea Pharmaceutical Distribution Association has faced extended periodIt is pointed out that the conflict between Hanmi Pharm and the Korea Pharmaceutical Distribution Association (KPDA) will be extended over the pharmaceutical e-commerce mall ‘On...
|
Bayer Korea has a high chance to take over ‘Mercilon’As Bayer Korea disposed its 4 oral contraceptives to Dong-A Pharmaceutical by sale, it now has a higher chance to take over ‘Mercilon.’
Since Dong-A Pharmaceutical took over th...
|
The Green Cross’s ‘Shinbaro’ has been approved for its safety and effectiveness in its Phase 4 clinical trialGreen Cross (President Eun-chul Huh) announced on the 7th that it unveiled the Pharse 4 clinical trial result of the arthritis treatment ‘Shinbaro Cap’ in its poster session at ...
|
SK Chemicals will enter the “global blood” product marketSK Chemicals has taken the first step to enhance and specialize in its new growth engine, the blood product business.
SK Chemicals (CEO Man-hoon Park) announced on the 7th that...
|
Samsung Pharm has established the partnership with the largest distribution company to expand to ChinaSamsung Pharm (President Ik-woo Lee) has established the foundation to expand to China by signing memorandum of understanding (MOU) to make a strategic partnership with the larg...
|
The 2 strong and the 1 medium has been formed by Bayer, Dong-A Pharmaceutical and Pfizer in the oral contraceptive market
As Dong-A Pharmaceutical took over the Bayer’s 4 oral contraceptives, the domestic oral
contraceptive market has become an arena for a domestic company, Dong-A Pharmaceutical, and two multinational companies, Bayer an...
Dong-A Pharmaceutical took over the Bayer’s 4 contraceptive products such as ‘Myvlar’
Dong-A Pharmaceutical (President and CEO Dong-wook Shin) announced on the 6th that it has taken over the 4 oral contraceptive products of Bayer, ‘Myvlar,’ ‘Meliane,’ ‘Minivlar,’ and ‘Triquilar.’
This takeover is the ...
A series of launches of targeted antibodies has enlarged the patient selection
As a series of anticancer drugs targeting a specific disease has acquired product approvals, it is expected that patients will have a larger choice.
Recently, Ono Pharmaceutical Korea has acquired a product approval...
The patient concentration effect of superior general hospitals are led by ‘Big 5 Hospitals’
While the patient concentration effect of superior general hospitals is led by so-called Big 5 Hospitals, which are university hospitals in Seoul, average out-of-area market share of the Big 5 Hospitals were 50.7% in ...
